The European Commission has granted marketing authorization in the European Union (EU) for new Eylea™ 8 mg (aflibercept 8 mg) for the treatment of neovascular (wet) age-related macular degeneration ...

The European Commission (EC) has approved Eylea 8 mg with extended treatment intervals of up to 6 months in neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular edema (DME) / ...

Committee for Medicinal Products for Human Use (CHMP) opinion is based on the findings from the pivotal clinical trials PULSAR in neovascular (wet) age-related macular degeneration (nAMD) and PHOTON ...

Bayer's 2026 Farm Tour with Luke Bryan collected 19,000+ food items, donated nearly 5,000 lbs of food, and supported 1 million meals through Feeding America. Watch how Bayer and Luke Bryan's Farm Tour ...

For people living with type 1 diabetes (T1DM), kidney health is an important part of lifelong care. Chronic kidney disease, or CKD, can develop gradually and may progress for years before symptoms ...

Exclusive license agreement includes rights to develop and commercialize Cedilla’s CyclinE1/CDK2 inhibitors / Assets are currently in pre-clinical development with potential to serve patients with ...

Kent Kalcevic’s story shows how a fifth-generation farmer responds to dry conditions by focusing on soil health, technology and the future of agriculture. His family has been operating a farm east of ...

Significant expansion of portfolio will advance Beiersdorf’s leading position as sun care expert / Beiersdorf delivers first major acquisition under its new C.A.R.E.+ strategy / Divestiture enables ...

Effective April 15, 2025, he will succeed Dr. Robert Reiter who has decided to retire after 27 years with the company and 34 years in the industry / Dr. Mike Graham has profound expertise in R&D and ...

Ruling should help significantly contain litigation by preempting conflicting state-law- based warning claims / Decision provides regulatory clarity for crop input producers, American farmers and ...

Licensing agreement enables Bayer to scale franchise in Europe and North America simultaneously / Bayer will combine elite germplasm, cutting-edge precision breeding engine and broad cereals expertise ...

Group sales rise 4.1 percent (Fx & portfolio adj.) to 13.405 billion euros, negative currency effect of 886 million euros / EBITDA before special items increases 9.0 percent to 4.453 billion euros, ...